Haemonetics Corp
NYSE:HAE
P/OCF
Price to OCF
Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.
Market Cap | P/OCF | ||||
---|---|---|---|---|---|
US |
Haemonetics Corp
NYSE:HAE
|
4.4B USD | 24.4 | ||
CH |
Alcon AG
SIX:ALC
|
39.6B CHF | 26.3 | ||
JP |
Hoya Corp
TSE:7741
|
6.5T JPY | 31.9 | ||
DK |
Coloplast A/S
CSE:COLO B
|
184.8B DKK | 81.3 | ||
US |
Align Technology Inc
NASDAQ:ALGN
|
19B USD | 24.2 | ||
US |
Cooper Companies Inc
NYSE:COO
|
18.1B USD | 32.1 | ||
CN |
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
59.5B CNY | 39.7 | ||
UK |
ConvaTec Group PLC
LSE:CTEC
|
5.1B GBP | 17.6 | ||
KR |
H
|
HLB Inc
KOSDAQ:028300
|
8.6T KRW | -67.8 | |
CH |
Ypsomed Holding AG
SIX:YPSN
|
5.3B CHF | 39.5 | ||
US |
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
5.6B USD | 13.3 |
P/OCF Forward Multiples
Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.